Fundación Para La Investigación Del Hospital Clínico De Valencia
Clinical trials sponsored by Fundación Para La Investigación Del Hospital Clínico De Valencia, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can 3D models outperform CT scans in judging pancreatic tumor shrinkage? Results expected Nov 2026 (estimated)
- Can a diabetes drug help dialysis patients with severe heart failure shed salt? Results expected Dec 2026 (estimated)
- Potassium binder may unlock lifesaving heart drugs for seniors Results expected Dec 2026 (estimated)
- Blood test could guide stronger chemo for colon cancer Results expected Jan 2027 (estimated)
- Three ways to trigger ovulation: which yields more mature eggs in Low-Reserve IVF? Results expected Jul 2027 (estimated)
-
Three ways to trigger ovulation: which yields more mature eggs in Low-Reserve IVF?
Disease control Recruiting nowResearchers compare three ovulation trigger approaches in women with low ovarian reserve undergoing fresh IVF cycles. Participants receive either human chorionic gonadotropin (hCG) alone, follitropin delta plus hCG, or a dual trigger using a GnRH agonist plus hCG. The trial measu…
Phase 3 • Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Potassium binder may let kidney patients keep Life-Saving heart drugs
Disease control Recruiting nowResearchers are testing whether sodium zirconium cyclosilicate (Lokelma) controls high potassium better than the usual approach of reducing or stopping RAASi and MRA medicines in people with chronic kidney disease. The trial enrolls adults with potassium levels between 5.0 and 6.…
Phase 3 • Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Can a powered stapler prevent leaks after colon surgery?
Disease control Recruiting nowThis trial compares a new powered circular stapler with standard manual staplers in patients having colorectal surgery. The goal is to see if the powered device reduces anastomotic leakage, a serious complication where the reconnected bowel leaks. Researchers will randomly assign…
Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Potassium binder may unlock lifesaving heart drugs for seniors
Disease control Recruiting nowThis study tests whether a potassium-lowering drug called sodium zirconium cyclosilicate (Lokelma) can help elderly patients with heart failure and chronic kidney disease safely take higher doses of RAASi medications, which are often limited by high potassium levels. The trial wi…
Phase 3 • Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Can 3D models outperform CT scans in judging pancreatic tumor shrinkage?
Diagnosis Recruiting nowResearchers are testing whether a 3D imaging model called 3D-PANC MSP is better than standard CT scans at showing how pancreatic tumors respond to chemotherapy before surgery. The study includes 70 patients with borderline or locally advanced pancreatic adenocarcinoma who have re…
Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia • Aim: Diagnosis
Last updated Sep 13, 2026 00:00 UTC
-
One-Time iron infusion could boost recovery in elderly heart patients
Symptom relief Recruiting nowThis study is testing whether a single intravenous dose of iron can improve quality of life and reduce frailty in adults aged 65 and older who have iron deficiency after a heart attack. About 538 participants will be randomly assigned to receive either the iron infusion or standa…
Phase 4 • Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Pacemaker study aims to boost stamina in stubborn heart failure
Symptom relief Recruiting nowThis study looks at whether a pacemaker can improve exercise ability and quality of life in people with heart failure with preserved ejection fraction (HFpEF) who also have a small heart chamber and a low heart rate during activity. About 30 participants will get a pacemaker and …
Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Can six weeks of leg presses recharge aging muscles?
Knowledge-focused Recruiting nowResearchers are investigating how mitochondria, the energy-producing structures inside muscle cells, relate to frailty in older adults. The study includes about 120 people: older adults with type 2 diabetes, healthy older adults, and healthy young adults. Everyone does a six-week…
Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC